NCT01936805已完成3 期
ROsuvastatin LOading and Clinical Outcomes Trial
Yuksek Ihtisas Hospital1 个研究点 分布在 1 个国家目标入组 299 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 299
- 试验地点
- 1
- 主要终点
- all cause death and composite of death or myocardial infarction from CV causes, TVR, or stroke
研究概览
简要总结
The aim of the present study was to evaluate the effect of pre-procedural single high loading dose (40 mg) of rosuvastatin on the primary end-points of all cause mortality and composite of death or myocardial infarction from cardiovascular (CV) causes, target vessel revascularization (TVR), or stroke.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •statin-naive patients
- •stable ischemic heart disease
- •de novo lesions appropriate for PCI
排除标准
- •current statin use
- •statin allergic patients
- •acute coronary syndromes
- •lesions not appropriate for PCI
- •refusal for participation
- •statin quitting during follow- up
研究组 & 干预措施
Rosuvastatin
Active Comparator
A 40 mg loading dose of rosuvastatin was administrated 24 h before the PCI.
干预措施: Rosuvastatin (Drug)
结局指标
主要结局
all cause death and composite of death or myocardial infarction from CV causes, TVR, or stroke
时间窗: 4 year
次要结局
- all cause death(4 year)
- composite of death or myocardial infarction from CV causes, TVR, or stroke(4 year)
研究者
Serkan Cay
Associate Professor
Yuksek Ihtisas Hospital
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Statins Evaluation in Coronary Procedures and Revascularization TrialAcute Coronary SyndromeNCT01448642Hospital do Coracao4,191
Unknown
3 期
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention StudyCoronary Artery DiseaseNCT01378715University Hospital, Motol400
撤回
1 期
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine TherapyBreast CancerNCT02483871Duke University
已完成
4 期
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) StudyA Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.NCT01971606Yonsei University234
已完成
3 期
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin ReloadingAssess the Periprocedural Myocardial NecrosisNCT01228227Gennaro Sardella310